Some clinical features of the combination of diabetes mellitus and COVID-19
- Autores: Elizarova I.O1, Chernykh T.M1, Zoloyedov V.I1
-
Afiliações:
- Voronezh State Medical University named after N.N. Burdenko
- Edição: Nº 4S (2022): Supplement
- Páginas: 46-49
- Seção: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277005
- DOI: https://doi.org/10.18565/therapy.2022.4suppl.46-49
- ID: 277005
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The most important challenge to modern medicine has become COVID-19 infection, which causes multiple organ lesions, including disorders of carbohydrate metabolism. The article presents the results of scientific observations on the effect of the SARS-CoV-2 virus on the course of diabetes mellitus.
Palavras-chave
Texto integral
Sobre autores
I. Elizarova
Voronezh State Medical University named after N.N. Burdenko
T. Chernykh
Voronezh State Medical University named after N.N. Burdenko
V. Zoloyedov
Voronezh State Medical University named after N.N. Burdenko
Bibliografia
- Зайратьянц О.В., Cамсонова М.В., Михалева Л.М. с соавт. Патологическая анатомия COVID-19: атлас. Под ред. О.В. Зайратьянца. М.: ГБУ «НИИОЗММ ДЗМ». 2020; 140 с.
- Вопросы оказания медицинской помощи населению в условиях распространения новой коронавирусной инфекции COVID-19. Методическое пособие. Под ред. В.М. Иванова,Т.Н. Петровой. Воронеж. 2021; 525 с.
- Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 15 от 22.02.2022. Минздрав России. Доступ: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/ВМР_COVID-19_V15.pdf (дата обращения - 04.04.2022).
- Эндокринопатии и COVID-19. Неотложные состояния, их профилактика и лечение. ФГБУ «НМИЦ эндокринологии» Минздрава России. Доступ:https://www.endocrincentr.ru/sites/default/files/all/news2020/COVID_REC/Эндокринопатии%20/o20COVID-19.%20Неотложные%20состояния%C2%A0их%20профилактика%20и%20лечение.pdf (дата обращения - 04.04.2022).
- Misra A., Ghosh A., Gupta R. Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification. Diabetes Metab Syndr. 2021; 15(1): 403-6. doi: 10.1016/j.dsx.2021.01.018.
- Rabbone I., Schiaffini R., Cherubini V., Scaramuzza A. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020; 43 (11): 2870-72. doi: 10.2337/dc20-1321.
- Lawrence C., Seckold R., Smart C. et al. Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID-19 pandemic. DiabetMed. 2021; 38(1): e14417. doi: 10.1111/dme.14417.
- Gregory J.M., Slaughter J.C., Duffus S.H. et al. COVID-19 severity is tripled in the diabetes community: A prospective analysis of the pandemic’s impact in type 1 and type 2 diabetes. Diabetes Care. 2021; 44(2): 526-32. doi: 10.2337/dc20-2260.
Arquivos suplementares
